Guatemala vs Guinea-Bissau: HIV/AIDS deaths averted by antiretroviral therapy
HIV/AIDS deaths averted by antiretroviral therapy over time
- Guatemala
- Guinea-Bissau
How they compare
Guinea-Bissau currently reports 1,774 deaths against 1,666 deaths in Guatemala, a difference of 108 deaths.
That makes Guinea-Bissau's figure about 1.1 times Guatemala's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Guinea-Bissau ahead.
Guatemala ranks 64th and Guinea-Bissau ranks 61st of 157 countries.
Across the 4 decades both report, Guatemala averaged higher in 2 and Guinea-Bissau in 1.
Head to head by decade
| Decade | Guatemala | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 674.44 deaths | 130.35 deaths | 544.08 deaths | Guatemala |
| 2010s | 1,601 deaths | 1,076 deaths | 524.42 deaths | Guatemala |
| 2020s | 1,629 deaths | 1,690 deaths | 60.83 deaths | Guinea-Bissau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Guatemala or Guinea-Bissau?
- Guinea-Bissau, at 1,774 deaths against 1,666 deaths in Guatemala as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Guatemala and Guinea-Bissau?
- 108 deaths, with Guinea-Bissau ahead.
- How many years of comparable data are there for Guatemala and Guinea-Bissau?
- 35 years are reported by both, from 1990 to 2024.
- How do Guatemala and Guinea-Bissau rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Guatemala ranks 64th and Guinea-Bissau ranks 61st of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.